984 results found

State attorneys general in Florida and Louisiana have filed lawsuits against pharmacy benefit managers alleging collusion and price-fixing of reimbursement rates paid to retail and independent pharmacies. These cases represent a growing trend of states pursuing antitrust enforcement actions against PBMs for allegedly coordinating to suppress pharmacy reimbursements.

In December 2012, the Department of Justice, Antitrust Division (DOJ) released a business review letter for STARS Alliance LLC.

The Trump Administration's Executive Order 14411 introduces sweeping changes to foreign importer of record (FIOR) rules that will fundamentally alter how Canadian businesses import goods into the United States. These new regulations eliminate informal entry options, impose stricter bonding requirements, and establish a minimum 50% penalty floor for non-compliance, placing unprecedented emphasis on accurate tariff classification, valuation, and origin declarations.

The Seventh Circuit held that Clorox's refusal to sell bulk-sized packages of certain products to some retailers, when it sold bulk-sized items to "big box" retailers was not a violation of the Robinson-Patman Act...

Natural Gas Act—Federal Preemption Of State-Law Antitrust Claims

James Bond preferred his martinis "shaken, not stirred" but what about Greek yogurt with fruit at the bottom?

The current Federal Trade Commission has little tolerance for companies that fail to take appropriate security measures to protect the financial data of their customers.

Rightly considered to be a "once in a generation decision," the UK electorate will on 23 June 2016 have a chance to vote on whether the UK should remain a member of the European Union.

Although it focuses specifically on a healthcare acquisition, the recent decision by the US Court of Appeals for the Ninth Circuit in St. Alphonsus Medical Center v. St. Luke's Health System is instructive on a broad range of antitrust issues.

The U.S. International Trade Commission has issued an exclusion order barring importation of certain older model Apple products for infringing a Samsung patent.

On January 13, 2017, the US Federal Trade Commission and US Department of Justice (collectively, the "Agencies") jointly issued revised Antitrust Guidelines for International Enforcement and Cooperation (the "Guidelines").

The U.S.-Canada trading relationship has reached a critical juncture as both nations implement escalating trade measures, with Canada's counter-tariffs taking effect and the United States responding with unprecedented import bans on Canadian alcoholic beverages, dairy products, and motorcycles. These actions mark a significant expansion of the Trump Administration's use of Section 338 of the Tariff Act of 1930, moving beyond additional tariffs to outright import restrictions. What does this escalation mean

On July 7, 2011, the US Federal Trade Commission (FTC) issued the most significant changes in decades to the premerger Notification and Report Form (the "Form") required under the Hart-Scott Rodino Act.

Recent testimony from the U.S. Department of Justice’s Antitrust Division and the FTC before the Senate Judiciary Committee focused on issues relating to standard-setting activities and competition policy.

The Department of Justice's ("DOJ") imposition of an $850,000 penalty against Biglari Holdings, Inc. for violating the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") illustrates both the agency's view of the limited scope of the passive investor exemption as well as their continued zeal for taking a hard line on HSR violations, even where it does not challenge the underlying bona fides of a transaction.

Effective September 4, 2024, non-compete agreements with all employees, including senior executives, will be prohibited by a new Federal Trade Commission (FTC) rule.

In a second hospital merger victory in a week for the Bureau of Competition at the Federal Trade Commission (FTC), Federal District Court Judge Kapala in the Northern District of Illinois granted the FTC’s motion for a preliminary injunction (PI) last week, stopping a merger between two hospital systems in Rockford, Illinois.

As reported previously, the first post-Actavis jury verdict in a "reverse payment" antitrust case handed a win to the defendants.